🇺🇸 FDA
Patent

US 6025369

N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

expired A61KA61K31/00A61K31/13

Quick answer

US patent 6025369 (N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/13, A61K31/135, A61K31/165